553 related articles for article (PubMed ID: 31530463)
41. Prevention of VTE Following total hip and knee arthroplasty in Hemophilia patients.
Stein MI; Park J; Raterman S
Orthopedics; 2011 May; 34(5):389-392. PubMed ID: 21553745
[TBL] [Abstract][Full Text] [Related]
42. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty.
Husted H; Otte KS; Kristensen BB; Ørsnes T; Wong C; Kehlet H
Acta Orthop; 2010 Oct; 81(5):599-605. PubMed ID: 20919815
[TBL] [Abstract][Full Text] [Related]
43. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
44. Thirty Days of Aspirin for Venous Thromboembolism Prophylaxis Is Adequate Following Total Knee Arthroplasty, Regardless of the Dose Used.
Shohat N; Ludwick L; Goel R; Ledesma J; Streicher S; Parvizi J
J Arthroplasty; 2021 Sep; 36(9):3300-3304. PubMed ID: 34052098
[TBL] [Abstract][Full Text] [Related]
45. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
Wilson DG; Poole WE; Chauhan SK; Rogers BA
Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and Safety of Mechanical IVC Filtration for Preventing Pulmonary Embolism in High-Risk Orthopedic Patients Undergoing Total Hip or Knee Arthroplasty.
Ahmed O; Kim YJ; Patel MV; Luu HH; Scott B; Cohen K
J Arthroplasty; 2021 Jul; 36(7):2586-2590. PubMed ID: 33741245
[TBL] [Abstract][Full Text] [Related]
47. Correlation of the Caprini Score and Venous Thromboembolism Incidence Following Primary Total Joint Arthroplasty-Results of a Single-Institution Protocol.
Bateman DK; Dow RW; Brzezinski A; Bar-Eli HY; Kayiaros ST
J Arthroplasty; 2017 Dec; 32(12):3735-3741. PubMed ID: 28734614
[TBL] [Abstract][Full Text] [Related]
48. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
[TBL] [Abstract][Full Text] [Related]
49. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
50. Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin.
Rahman WA; Habsa GH; Al-Mohrej OA; Hammad M; Selim NM; Hammad A
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020938865. PubMed ID: 32700655
[TBL] [Abstract][Full Text] [Related]
51. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.
He ML; Xiao ZM; Lei M; Li TS; Wu H; Liao J
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD008207. PubMed ID: 25069620
[TBL] [Abstract][Full Text] [Related]
52. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
[TBL] [Abstract][Full Text] [Related]
53. Aspirin for thromboprophylaxis after primary lower limb arthroplasty: early thromboembolic events and 90 day mortality in 11,459 patients.
Ogonda L; Hill J; Doran E; Dennison J; Stevenson M; Beverland D
Bone Joint J; 2016 Mar; 98-B(3):341-8. PubMed ID: 26920959
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study.
Nemeth B; Smeets M; Pedersen AB; Kristiansen EB; Nelissen R; Whyte M; Roberts L; de Lusignan S; le Cessie S; Cannegieter S; Arya R
J Thromb Haemost; 2024 Jan; 22(1):238-248. PubMed ID: 38030547
[TBL] [Abstract][Full Text] [Related]
55. Development and Validation of a Risk Stratification System for Pulmonary Embolism After Elective Primary Total Joint Arthroplasty.
Bohl DD; Maltenfort MG; Huang R; Parvizi J; Lieberman JR; Della Valle CJ
J Arthroplasty; 2016 Sep; 31(9 Suppl):187-91. PubMed ID: 27067463
[TBL] [Abstract][Full Text] [Related]
56. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Bawa H; Weick JW; Dirschl DR; Luu HH
J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
[TBL] [Abstract][Full Text] [Related]
57. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?
Eikelboom JW; Karthikeyan G; Fagel N; Hirsh J
Chest; 2009 Feb; 135(2):513-520. PubMed ID: 19201714
[TBL] [Abstract][Full Text] [Related]
58. Venous thromboembolism after fast-track unicompartmental knee arthroplasty - A prospective multicentre cohort study of 3927 procedures.
Petersen PB; Jørgensen CC; Gromov K; Kehlet H;
Thromb Res; 2020 Nov; 195():81-86. PubMed ID: 32673960
[TBL] [Abstract][Full Text] [Related]
59. Incidence and risk factors associated with venous thromboembolism following primary total hip arthroplasty in low-risk patients when using aspirin for prophylaxis.
Howard TA; Judd CS; Snowden GT; Lambert RJ; Clement ND
Hip Int; 2022 Sep; 32(5):562-567. PubMed ID: 33594900
[TBL] [Abstract][Full Text] [Related]
60. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.
He ML; Xiao ZM; Lei M; Li TS; Wu H; Liao J
Cochrane Database Syst Rev; 2012 Jan; 1():CD008207. PubMed ID: 22258981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
